Medicenna Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 360,000 | 0.461% |
| Private Companies | 5,500,000 | 7.04% |
| VC/PE Firms | 9,857,863 | 12.6% |
| Individual Insiders | 11,812,292 | 15.1% |
| General Public | 50,627,745 | 64.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.2%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,762,802 | US$6.2m | 0% | no data | |||
| 5,596,490 | US$6.0m | 0% | no data | |||
| 5,500,000 | US$5.9m | 0% | no data | |||
| 5,268,788 | US$5.7m | 0% | 0.07% | |||
| 4,589,075 | US$4.9m | 0% | 2.37% | |||
| 325,000 | US$349.0k | 0% | no data | |||
| 235,000 | US$252.4k | 0% | 0.92% | |||
| 125,000 | US$134.2k | 25% | 0.02% | |||
| 83,000 | US$89.1k | 0% | no data | |||
| 25,000 | US$26.8k | 0% | no data | |||
| 20,000 | US$21.5k | 0% | no data |